Document Detail


Management of gestational trophoblastic neoplasia.
MedLine Citation:
PMID:  19332252     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Molar pregnancy and gestational trophoblastic neoplasms (GTN) comprise a group of interrelated diseases with a varying degree of aggressiveness. Complete and partial molar pregnancy, invasive mole, placental site trophoblastic tumor (PSTT), and choriocarcinoma cover the spectrum of GTN. GTN is one of the few highly curable human tumors, even in the setting of advanced disease and widespread metastases. Although GTN typically follows a molar pregnancy, they can occur after any gestational event. This review discusses the basic principles of management and recent advances in the diagnosis and treatment of patients with GTN.
Authors:
Neil S Horowitz; Donald P Goldstein; Ross S Berkowitz
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in oncology     Volume:  36     ISSN:  0093-7754     ISO Abbreviation:  Semin. Oncol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-31     Completed Date:  2009-05-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0420432     Medline TA:  Semin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  181-9     Citation Subset:  IM    
Affiliation:
New England Trophoblastic Disease Center, Brigham and Women's Hospital, Department of Obstetrics and Gynecology, Boston, MA 02115, USA. nhorowitz@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Gestational Trophoblastic Neoplasms / diagnosis,  pathology,  therapy*
Humans
Pregnancy
Prognosis
Uterine Neoplasms / diagnosis,  pathology,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the...
Next Document:  Assessment of peripheral endothelial-dependent vasodilatation within the first year after heart tran...